Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice

5 Jan 2024

Abstract excerpt

The recent FDA approval of amyloid-lowering drugs is changing the landscape of Alzheimer disease (AD) clinical practice. Previously, apolipoprotein E (APOE) genetic testing was not recommended in the care of people with AD because of limited clinical utility. With the advent of amyloid-lowering drugs, APOE genotype will play an important role in guiding treatment recommendations. Recent clinical trials have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Health Systems, Economic Evaluations, Quality of Life

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38223345
DOI: 10.1212/cpj.0000000000200230

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 16 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical PracticePMID 38223345Read ↗

Advances in genetic testing for Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.Semantic proximity Read ↗

Genetic testing for Alzheimer's disease.Semantic proximity Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Genetic testing for Alzheimer disease. Practical and ethical issues.Semantic proximity Read ↗

Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.Semantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.Semantic proximity Read ↗

Genetic testing in dementia - utility and clinical strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.